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demonstrate that uponmitochondrial outermembrane permeabilization physiological expression levels of XIAP
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Apoptosis is an evolutionary conserved cell suicide mechanism that
is essential from developmental stages to adulthood to provide tissue
homeostasis and to delete damaged and superﬂuous cells in all
metazoans. In most cells, proapoptotic signals result in the activation
of Bcl-2 family members Bax and Bak which form pores in the
mitochondrial outer membrane [1–3]. Via these pores mitochondrial
inter-membrane space proteins, such as cytochrome c and second
mitochondria-derived activator of caspases (Smac) are released
simultaneously into the cytosol [4,5]. In presence of dATP/ATP,
cytochrome c and apoptotic protease activating factor-1 form the
caspase-9-activating apoptosome complex [6]. Caspase-9 cleaves and
activates executioner caspase-3 and -7 which are essential to the
executionof apoptotic cell death. x-Linked inhibitor of apoptosis protein
(XIAP) is themost potent natural inhibitor of caspases-9, -3, and -7, andcaspase activation is efﬁciently prevented if XIAP expression exceeds a
critical threshold concentration [7,8]. XIAP consists of three baculoviral
IAP repeat (BIR) domains and a COOH-terminal RING domain [9]. The
linker region preceding BIR2 is responsible for the inhibition of caspase-
3 and -7,which is further stabilized by interactionwith the BIR2 domain
itself [10,11]. The BIR3 region binds to the NH2 terminus of caspase 9,
which is exposed upon cleavage and activation [12].
XIAP is efﬁciently antagonized by Smac. Smac is synthesized as
a cytosolic precursor protein and is proteolytically processed upon
import into themitochondria, leaving themature 21 kDa Smac protein
[13,14]. The functional XIAP-antagonizing region of Smac is restricted
to the NH2-terminal AVPI sequence. Via this AVPI sequence Smac
can relieve XIAP-mediated inhibition of both initiator caspase-9 and
effector caspases-3 and -7 [15–17]. Binding of Smac to the BIR3 region
competitively inhibits binding of XIAP to caspase-9, while binding to
the BIR2 region sterically hinders the interaction of XIAPwith caspase-
3 and -7. It was recently shown that once Bax/Bak pores have formed
in the outer mitochondrial membrane, XIAP can kinetically impair or
even restrict the release of Smac from the intermembrane space by
direct XIAP–Smac interaction [18]. Smac dimerizes via an extended
hydrophobic interface and forms an unusual, elongated arch shaped
quaternary structure, causing Smac dimers to migrate at an unusually
large apparent molecular weight of approximately 100 kDa [14,17].
Alongwith theXIAPbinding ability of Smacwe therefore hypothesized
that Smac dimerization may be implicated in the XIAP-mediated
limitation of Smac release. We addressed this question by conducting
single-cell real-time measurements of the release kinetics and release
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pression levels of XIAP.
2. Results
2.1. Mitochondrial localization of Smac fusion proteins and interaction
with XIAP
To visualize and measure the subcellular distribution of Smac or
Smac mutants in individual living cells, we expressed fusion proteins
comprised of Smac, a short ﬂexible linker sequence, and yellow
ﬂuorescent protein (YFP). Corresponding to earlier studies in various
other cell systems [4,5,18,19], Smac-YFP localized to the mitochon-
dria, as shown by colocalization of the YFP signal withmitotracker red
ﬂuorescence in DLD-1 colon cancer cells (Fig. 1a). A Smac-YFP fusion
protein incapable of forming dimers was generated by inserting a
pointmutation (F33D) into the dimerization interface by site-directed
mutagenesis. The F33Dmutationwas previously shown to completely
abrogate Smac dimerization [17]. Smac(F33D) probes likewise located
entirely to mitochondria (Fig. 1b). Exclusive mitochondrial localiza-
tion of wild type Smac and monomeric Smac probes was also ob-
served in HCT-116 cells (not shown).
To investigate whether recombinantly expressed dimeric or
monomeric Smac probes interact with XIAP, immunoprecipitation
experiments were conducted in HCT-116 cells deﬁcient of native
Smac (Fig. 1c, d). Since the band for native XIAP overlaps with the
signal of the IgG heavy chain during gel electrophoresis, we expressed
a XIAP variant fused to Cerulean ﬂuorescent protein via ﬂexible
linkers (C-XIAP-C). We previously showed that C-XIAP-C retains the
anti-apoptotic features of native XIAP since it interacts with native
Smac and reduces effector caspase activities to similar extents as the
wild type protein [18]. As expected, both Smac and Smac(F33D)
probes interacted with C-XIAP-C (Fig. 1d). Instead, a Smac variant
carrying a point mutation in the IAP binding motif (A1M) could not
interact with XIAP (Fig. 1d, lane 9). Since XIAP was suggested to form
dimers via the BIR1 domain [20], we also generated a corresponding
dimerization-deﬁcient XIAP variant (C-XIAP-C(V86E)). C-XIAP-C
(V86E) interacted with both Smac and Smac(F33D) probes (Fig. 1d,
lanes 5 and 7), but not with the Smac(A1M) probe (Fig. 1d, lane 11).
Since the Smac fusion proteins retained the localization and XIAP
interaction properties of native Smac, these probes in the following
were used in time-lapse imaging experiments to investigate the
Smac-XIAP interplay during apoptosis signalling.
2.2. Physiological XIAP expression prolongs the release duration of
dimeric but not monomeric Smac during intrinsically and extrinsically
induced apoptosis
Since cells within a population undergomitochondrial outermem-
brane permeabilization individually at different times [21], we
employed live cell imaging to obtain the real-time signalling kinetics
of single cells. We ﬁrst investigated the release kinetics of dimeric and
monomeric Smac probes from the mitochondria into the cytosol
during staurosporine (STS) induced apoptosis in parental DLD-1 cells
or DLD-1 cells deﬁcient in XIAP expression (DLD-1 xiap−/0).
We found that physiological XIAP expression in DLD-1 cells resulted
in the Smac probe being released considerably slower than in DLD-1
xiap−/0 cells (Fig. 2a–c). Since Smac dimers form an outstretched, rigid
arch [17], we asked whether the elimination of Smac dimerization
would abrogate the potential of XIAP to prolong Smac release. The
monomeric Smac(F33D) probe was released from mitochondria and
distributed homogeneously throughout the cytosol in both DLD-1 and
DLD-1 xiap−/0 cells (Fig. 2d, e), and, indeed, discrepancies in release
kinetics between parental and XIAP-deﬁcient cells could no longer be
observed (Fig. 2f). When we compiled data from all cells measured, for
statistical comparison, our observations were corroborated. Physiolog-ical XIAP expression signiﬁcantly extended Smac release to a duration of
approximately 60 min, whereas the release durations of monomeric
Smac were not affected (Fig. 2g). Similar results were measured when
inducingapoptosis via theextrinsic apoptosis pathwayusingTRAIL/CHX
(Fig. 2h). Corresponding results on release kineticswere alsoobtained in
parental and XIAP-deﬁcient HCT-116 cells in response to STS or TRAIL/
CHX (Fig. 2i, j). In all scenarios Smac was fully released, as determined
from homogeneous YFP ﬂuorescence distribution following release, as
well as from similar cellular ﬂuorescence standard deviations across all
conditions (Fig. 3a–d). Taken together, these results therefore suggest
that the release duration of dimeric Smac, but not monomeric Smac, is
prolonged by physiological XIAP levels, but that Smac is ultimately
released maximally in all DLD-1 and HCT-116 cells.
2.3. Incomplete release of dimeric Smac but not monomeric Smac in
presence of elevated XIAP expression
It was recently shown that cells expressing elevated amounts of
XIAP are not capable of releasing their entire pool of Smac subsequent
to mitochondrial outer membrane permeabilization since the rapid
interaction of Smac and XIAP seems to block the release pores [18].
Since the above data indicated that Smac dimerization is required for
XIAP to prolong the release duration of Smac, we hypothesized that
the dimerization of Smac may likewise be required for mitochondrial
Smac retention at conditions of elevated XIAP expression. We
established elevated XIAP levels by expressing the C-XIAP-C probe
and compared the release of dimeric and monomeric Smac variants.
For these experiments we employed Smac-deﬁcient HCT-116 cells
(HCT-116 smac−/−) to exclude that pore obstructions, resulting from
the interaction of endogenous Smac with C-XIAP-C, interfere with the
measurements. Cerulean ﬂuorescent protein was expressed in control
experiments. Time-lapse imaging of STS treated HCT-116 smac−/−
cells indicated that both Smac and Smac(F33D) probes were fully
released in Cerulean-expressing control cells, and that, as expected,
Smac(F33D) release proceeded slightly faster (Fig. 4a, b). The small
increase in the release kinetic did not reﬂect in accelerated apoptosis
execution, as determined from the time required from onset of Smac
release until maximal cellular shrinkage (Supplemental Figure 1). In
cells expressing elevated amounts of XIAP, again Smac but not Smac
(F33D) release seemed prolonged (Fig. 4c). However, a remaining
punctate staining subsequent to release onset could be observed in
cells expressing the wild type Smac probe (Fig. 4c). Likewise, plotted
temporal proﬁles conﬁrmed that Smac but not Smac(F33D) could be
retainedmitochondrially by elevated amounts of XIAP (Fig. 4d).When
we collated data from all cells analysed for statistical analysis, we
could conﬁrm that the release duration of dimeric Smac was
prolonged (Fig. 4e), and that Smac release remained incomplete in
presence of C-XIAP-C expression (Fig. 4f–g). In contrast, the duration
and amounts of Smac(F33D) release were not affected (Fig. 4e–g).
Since XIAP can dimerize via its BIR1 domain [20], we also in-
vestigated whether BIR1 dimerization at elevated XIAP levels may
contribute to impaired Smac release. Using a C-XIAP-C variant incapable
of BIR1dimerization (C-XIAP-C(V86E)) did, however, not enhance Smac
release (Supplemental Fig. 2). In conclusion, our data therefore show
that dimeric Smac but not monomeric Smac can be selectively retained
inside the mitochondria in presence of elevated XIAP expression, and
that this retention is independent of the BIR1 dimerization status of
XIAP.
3. Discussion
In this studywe identiﬁed that the capability of Smac to formdimers
is crucial for XIAP to prolong and limit the release of Smac from the
mitochondrial inter-membrane space into the cytosol during apoptosis.
The release of monomeric Smac, in contrast, is always complete and
kinetically invariant, irrespective of whether XIAP is absent or present.
Fig. 1.Mitochondrial localization of Smac fusion proteins and interaction with XIAP. (a, b) DLD-1 cells transiently transfected to express (a) Smac-YFP or (b) Smac(F33D)-YFP were
incubated with mitotracker red (50 nM) to investigate the subcellular localization of Smac probes. Cells were imaged 24 h post transfection. Scale bar=10 μm. Insets are magniﬁed
selections of the images and demonstrate that all YFP ﬂuorescence emerged from mitochondrial regions. (c, d) Interaction of Smac and XIAP variants. HCT-116 smac−/− cells were
transiently transfected to express Smac-YFP, Smac(F33D)-YFP or Smac(A1M)-YFP in parallel with C-XIAP-C or C-XIAP-C(V86E). (c) Demonstrating successful transfection and
expression, all Smac and XIAP variants could be detected in whole cell extracts which served as input material for the subsequent immunoprecipitation. (d) Immunoprecipitation
was performed in native cell extracts with a Smac bait antibody. Following Western blotting, C-XIAP-C or C-XIAP-C(V86E) was detected with an antibody directed against XIAP.
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Fig. 2. Physiological XIAP expression prolongs the release duration of dimeric but notmonomeric Smac during intrinsically and extrinsically induced apoptosis. (a, b) DLD-1 or DLD-1
xiap−/0 cells releasing Smac-YFP in response to 1 μM STS are shown. Upon release, mitochondrial Smac-YFP ﬂuorescence drops and redistributes throughout the cell. Time relates to
onset of Smac-YFP release (mitochondrial outer membrane permeabilization). Scale bar=10 μm. (c) Temporal proﬁles of Smac-YFP release in DLD-1 (dashed line) or DLD-1 xiap−/0
(black) cells. Smac-YFP release was plotted as the change in cellular ﬂuorescence standard deviation and is shown for three representative cells each. Release onset was set to time
zero. Smac-YFP release proceeded rapidly in XIAP-deﬁcient cells, but in contrast was prolonged in parental cells. A total of n=22 DLD-1 or n=20 DLD-1 xiap−/0 cells were analyzed.
(d, e) As in (a, b) DLD-1 or DLD-1 xiap−/0 cells releasing Smac(F33D)-YFP in response to 1 μM STS are shown. Scale bar=10 μm. (f) As in (c), temporal proﬁles of Smac(F33D)-YFP
release in DLD-1 (dashed line) or DLD-1 xiap−/0 (black) cells are shown. Release onset was set to time zero. Smac(F33D)-YFP release proceeded rapidly in both parental and XIAP-
deﬁcient cells. A total of n=17 DLD-1 cells or n=17 DLD-1 xiap−/0 cells were analysed. (g) The duration of Smac-YFP or Smac(F33D)-YFP release in response to 1 μM STS was
quantiﬁed for parental and XIAP-deﬁcient DLD-1 cells. Data are means from n=22, 20, 17 and 17 cells per group. (h) The duration of Smac-YFP or Smac(F33D)-YFP release in
response to 100 ng/ml TRAIL/1 μg/ml CHXwas quantiﬁed for parental and XIAP-deﬁcient DLD-1 cells. Data are means from n=19, 17, 16 and 17 cells per group. (i, j) As in (g, h), the
duration of Smac-YFP or Smac(F33D)-YFP release in response to STS (i) or TRAIL/CHX (j) was quantiﬁed for parental and XIAP-deﬁcient HCT-116 cells. Data aremeans from n=9, 10,
10 and 10 cells per group (STS treatment), or from n=10, 12, 9 and 12 cells per group (TRAIL/CHX treatment). Error bars in all panels represent s.e.m. Asterisks indicate signiﬁcant
differences (pb0.05; ANOVA and subsequent Tukey's test).
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cytochrome c, which has been described to proceed swiftly in various
experimental systems and seems only limited by the velocity of Bax/Bak
pore formation [4,5,21,22].
Both Smac and cytochrome c are of low molecular weight. While
native cytochrome c is a monomeric protein [23], Smac homodi-
merizes at physiological conditions via an extensive hydrophobic
interface, and the quaternary structure of dimeric Smac resembles an
unusual, long and outstretched arch [17]. Smac binds to both the BIR2
and BIR3 regions of XIAP and antagonizes the inhibition of effector
caspase-3, -7 and -9 [15–17], and dimeric Smac outperforms
monomeric Smac in promoting the release of inhibited effector
caspases from XIAP [17]. In a recent study using short dimeric and
monomeric Smac-mimicking peptides, this has been attributed to a
two-step binding mechanism of dimeric Smac to XIAP [24]: Smacpreferentially binds to the BIR3 region, and this binding further
promotes binding to the BIR2 region and promotes the dissociation of
activated effector caspases from XIAP. In agreement with this, a
preceding study found that the Kd of Smac and the BIR2 domain is
approximately 5-fold higher than the Kd of Smac and the BIR3 domain
[15]. Short dimeric peptides containing the IAP binding motif
therefore are sufﬁcient to match the proapoptotic potential of native
dimeric Smac, and thereby question whether the rigid, outstretched
arch structure established upon Smac dimerization has any functional
role.
We collected evidence that the unusual, non-globular conforma-
tion of dimeric Smac could be an important contributor towards
kinetically impairing or limiting the release of Smac through Bax/Bak
pores, a phenomenon that might be further promoted through
the tighter binding of dimeric Smac to XIAP [17]. In line with this
Fig. 3. Physiological XIAP expression does not affect the quantities of Smac-YFP release. (a) Comparison of the amounts of Smac-YFP and Smac(F33D)-YFP released in response to 1 μM
STS. Cellular ﬂuorescence standard deviationswere quantiﬁed for all DLD-1 andDLD-1 xiap−/0 cellsmeasured. Data from n=22, 20, 17 and 17 cells per groupwere compared at 60, 90,
120 min after onset of Smac-YFP/Smac(F33D)-YFP release. (b) Comparison of the amounts of Smac-YFP and Smac(F33D)-YFP released in response to 100 ng/ml Trail plus 1 μMCHX.
Data are from n=19, 17, 16 and 17 cells per group. (c) Comparison of amounts of Smac-YFP or Smac(F33D)-YFP released inHCT-116 andHCT-116 xiap−/0 cells in response to 1 μMSTS
were compared. Data are from n=9, 10, 10 and 10 cells per group. (d) Comparison of the amounts of Smac-YFP and Smac(F33D)-YFP released in response to 100 ng/ml Trail plus 1 μM
CHX. Data are from n=10, 12, 9 and 12 cells per group. Data in all panels are shown as means; error bars represent s.e.m. n.s., Not signiﬁcant (ANOVA and subsequent Tukey's test).
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media, native Smac was found to migrate at an apparent molecular
mass of 100 kDa [14]. Presence of XIAP is, however, required to impairor limit the release of dimeric Smac. Previously published data
suggested that XIAP can bind to Smac at or within the mitochondria
once Bax/Bak release pores open [18], suggesting that dimeric Smac
Fig. 4. Incomplete release of dimeric Smac but not monomeric Smac in presence of elevated XIAP expression. (a) Cerulean-expressing HCT-116 smac−/− cells releasing Smac-YFP or
Smac(F33D)-YFP in response to 1 μM STS are shown. Upon release, mitochondrial Smac-YFP ﬂuorescence drops and redistributes throughout the cell. Time relates to onset of Smac
release (mitochondrial outer membrane permeabilization). Scale bar=10 μm. (b) Temporal proﬁles of Smac-YFP (dashed line) or Smac(F33D)-YFP (black) release in Cerulean-
expressing HCT-116 smac−/− cells. Smac release was plotted as the change in cellular ﬂuorescence standard deviation and is shown for three representative cells each. Release onset
was set to time zero. Smac-YFP was prolonged when compared to Smac(F33D)-YFP release. (c) C-XIAP-C expressing HCT-116 smac−/− cells releasing Smac-YFP or Smac(F33D)-YFP
in response to 1 μM STS are shown. Upon release, mitochondrial Smac-YFP ﬂuorescence drops and redistributes throughout the cell. Time relates to onset of Smac release. Scale
bar=10 μm. (d) Temporal proﬁles of Smac-YFP (dashed line) or Smac(F33D)-YFP (black) release in C-XIAP-C expressing HCT-116 smac−/− cells. Smac release was plotted as the
change in cellular ﬂuorescence standard deviation and is shown for three representative cells each. Release onset was set to time zero. Smac-YFP was prolonged and incomplete
when compared to Smac(F33D)-YFP release. (e) The duration of Smac-YFP or Smac(F33D)-YFP release in response to 1 μM STS was quantiﬁed for all HCT-116 smac−/− cells
measured. Data are means from n=11, 11, 9 and 10 cells per group. Error bars represent s.e.m. Asterisk indicates signiﬁcant difference (pb0.05; ANOVA and subsequent Tukey's
test). (f) Comparison of amounts of Smac-YFP and Smac(F33D)-YFP released in response to 1 μM STS was quantiﬁed for all Cerulean expressing cells measured. Cellular ﬂuorescence
s.d. for n=11 and 11 cells per group were compared at 60, 90 and 120 min after onset of Smac release. Data are shown as means; error bars represent s.e.m. n.s., Not signiﬁcant
(Student's t tests). (g) Comparison of amounts of Smac-YFP and Smac(F33D)-YFP released in response to 1 μM STS were quantiﬁed for all C-XIAP-C expressing cells measured.
Cellular ﬂuorescence s.d. for n=9 and 10 cells per group were compared at 60, 90 and 120 min after onset of Smac-YFP/Smac-YFP(F33D) release. All data are shown as means; error
bars represent s.e.m. Asterisk indicates signiﬁcant reduction in the amount of Smac release (pb0.05; Student's t tests).
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through the Bax/Bak release pores, or may even block these pores in
living cells. Since the binding of Smac to XIAP is mediated by a ﬂexible,
unstructured NH2-terminal sequence [17], it seems plausible that
monomeric Smac in contrast cannot form such rigid, release-impaired
structures with XIAP.
Of note, previously published in vitro data indicated that Bax pores
in cardiolipin enriched liposomes can grow to sizes which allow the
release of very large, 2 MDa dextran molecules [25]. Here and also in a
previous study [18] we could instead show that the sizes of Bax/Bakpores within living cells are size limited. The presence of other
proteins and protein clusters in the outer mitochondrial membrane
[26] may sterically prevent Bax/Bak pores to grow to such enormous
sizes. Likewise, limitations in cardiolipin accessibility in the outer
mitochondrial membrane could restrict pore sizes.
The ﬁnding that Bax/Bak pores might be blocked through Smac-
XIAP interaction at a ﬁrst glance seems to contradict the fact that cyt-c
is still released efﬁciently at conditions of elevated XIAP expression
[18]. However, the time required to fully block the pores, as evidenced
by stoppage of Smac release in presence of highXIAP concentrations, is
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of time to fully release cyt-c, since cyt-c release reaches completion
within 5–10 min, as demonstrated previously in various cell lines
[4,5,18,21].
The dissociation constant (Kd) of dimeric Smac was determined to
lie in the zeptomolar range [27], indicating that the arch-shaped
dimeric Smac structure effectively cannot dissociate. This agrees with
our observation that in the presence of high levels of XIAP mito-
chondrial retention of Smac can persist for hours subsequent to Bax/
Bak pore formation. Importantly, postmitotic cells such as neurons,
skeletal muscle cells and cardiomyocytes are particularly resistant to
apoptosis execution following mitochondrial outer membrane per-
meabilization, and physiological XIAP expression in mouse cortical
neuronswas shown to be sufﬁciently high to prevent full Smac release
[18,28–31]. The potent function of XIAP in postmitotic cells arises
during cellular differentiation and harvested from Smac-deﬁcient
mice and reconstituted to express Smac-YFP or Smac(F33D)-YFP, such
cells could pose suitable model systems to test the physiological
relevance of mitochondrial Smac retention. Especially in not fully
differentiated cells in which cytosolic Smac could potentially still
override the inhibitory potential of XIAP, the inﬂuence and potentially
physiological role of mitochondrial retention of dimeric Smac could be
investigated.
4. Methods
4.1. Materials
Recombinant soluble human “killer” TRAIL and STS were from
Alexis (San Diego, CA). Embryo-tested mineral oil and cycloheximide
(CHX) as well as all other chemicals came in analytical grade purity
from Sigma-Aldrich (Tallaght, Dublin, Ireland).
4.2. Plasmids and molecular cloning
pSmac-YFP, pSmac(A1M)-YFP and C-XIAP-C were described
before [4,18,32]. Point mutations were introduced by site-directed
mutagenesis using KOD Hot Start Polymerase (Novagen, Merck
Biosciences, Nottingham, UK). Sense and antisense primers for the
different mutations were as follows.
p-Smac(F33D)-YFP: 5′-GTAACAGATAGCACCTCTACCGATCTGTCT-
CAAACCACCTACG-3′ and 5′-CGTAGGTGGTTTGAGACAGATCGGTA-
GAGGTGCTATCTGTTAC-3′;
pC-XIAP-C V86E: 5′-GGAAGACACAGGAAAGAATCCCCAAATTG-
CAG-3′ and 5′-CTGCAATTTGGGGATTCTTTCCTGTGTCTTCC-3′.
Coding sequences were veriﬁed by sequencing.
4.3. Cell culture and transfection
Cells were cultured in RPMI 1640 medium supplemented with
penicillin (100 μg/ml), streptomycin (100 μg/ml) and 10% heat
inactivated fetal calf serum (Sigma-Aldrich) at 37 °C and 5% CO2. For
transfection, 0.5 μg of plasmid DNA and 1 μl Turbofect (Fermentas
GmbH, Germany) were incubated in 100 μl of serum-free medium for
20 min at room temperature. The transfection mix was added
dropwise to 1 ml culture media and left on the cells at 37 °C
overnight. XIAP-deﬁcient DLD-1 and HCT-116 cells and Smac-
deﬁcient HCT-116 cells were described before [33,34].
4.4. Immunoprecipitation
For immunoprecipitation studies, cells were cultivated in a T75
culture ﬂask in 12 ml of medium and grown to 80% conﬂuency. Cellswere transfected with pC-XIAP-C, pC-XIAP-C(V86E), pSmac-YFP,
pSmac(A1M)-YFP or pSmac-YFP(F33D)-YFP as described above.
Cells were trypsinized and collected at 1000 rpm for 3 min and
washed with phosphate-buffered saline. The cell pellet was resus-
pended in NP-40 lysis buffer (50 mM Tris–HCl pH 8.0, 150 mM NaCl,
1% NP-40, 0.5 M EDTA, protease inhibitor cocktail 1:100 Sigma-
Aldrich, Ireland) and homogenized with a needle and syringe.
Samples were ﬁrst incubated overnight at 4 °C with 5 μg rabbit
polyclonal Smac antibody (AF-789, R&D Systems, Minneapolis, USA)
(test sample), or 5 μg anti-rabbit IgG antibody (control sample) and
then incubated with protein A/G agarose beads (Santa Cruz
Biotechnology, CA, USA) for 2 h at 4 °C. The protein–bead complex
was collected by centrifugation, boiled and samples were subjected to
Western blotting.
4.5. Preparation of whole cell extracts and Western blotting
For whole cell extracts, cells were collected at 400×g for 3 min and
washed with phosphate-buffered saline. Whole cell extracts were re-
suspended in lysis buffer (62.5 mM Tris–HCl, pH 6.8, 10% (v/v)
glycerin, 2% (w/v) SDS, 1 mM phenylmethylsulfonyl ﬂuoride, 1 μg/ml
pepstatin A, 1 μg/ml leupeptin, and 5 μg/ml aprotinin) and heated at
95 °C for 20 min. Protein content was determined with the Pierce
Micro-BCA protein assay (Pierce, Northumberland, UK). An equal
amount of protein (20 μg) was loaded onto SDS-polyacrylamide gels.
Proteins were separated at 100 V for 2.5 h and then blotted to
nitrocellulose membranes (Protean BA 83; 2 μm; Schleicher &
Schuell) in transfer buffer (25 mM Tris, 192 mM glycine, 20%
methanol (v/v), and 0.01% SDS) at 18 V for 60 min. The blots were
blocked with 5% nonfat dry milk in TBST (15 mM Tris–HCl, pH 7.5,
200 mM NaCl, and 0.1% Tween 20) at room temperature for 1 h.
Membranes were incubated with the following antibodies: a mouse
monoclonal XIAP antibody (610763, clone 48, BD Transduction
Laboratories, CA, USA) or a rabbit polyclonal Smac antibody (AF-
789, R&D Systems, Minneapolis, USA). Membranes were washed with
TBST three times for 5 min and incubated with anti-mouse peroxi-
dase-conjugated secondary antibodies (Jackson Laboratories) for 1 h.
Blots were washed and developed using the enhanced chemilumi-
nescence detection reagent (Millipore, Ireland). Chemiluminescence
was detected at 12-bit dynamic range using a Fuji LAS 4000 CCD
system (Fujiﬁlm UK Ltd., Bedfordshire, UK).
4.6. Time-lapse microscopy and digital imaging
Cellswere cultivated on glass bottomdishes (Willco BV, Amsterdam,
The Netherlands) in 200 μl of medium at least overnight to let them
attach ﬁrmly. For time-lapse imaging, the culture media was buffered
with HEPES (10 mM; pH 7.4) and covered with mineral oil. Apoptosis
was induced on stage with 1 μM STS or 100 ng/ml TRAIL plus 1 μg/ml
CHX. Control experiments were performed to exclude phototoxicity of
the imaging procedure. Cells were monitored confocally using an LSM
5livemicroscope (Carl ZeissMicroImaging, Inc.) equippedwith a40×oil
ﬂuorescence objective and a temperature controlled incubation
chamber. The confocal laser scanning unit was equipped with a 405-
nm argon laser (Cerulean excitation), a 489-nm argon laser (YFP
excitation), and a 561-nm argon laser (Mito tracker red excitation).
Images were analyzed using Metamorph software (Molecular Devices,
UK). The release kinetics of Smac probes was shown as standard
deviation (s.d.) from the average pixel intensity of individual cells.
Compartmentalized Smac probes contribute to a high s.d., and a
homogeneous distribution results in a low s.d. Baselines before the
releasewere scaled to 100%. To quantify the time required fromonset of
Smac release until maximal cellular apoptotic shrinkage (determined
from differential interference contrast images), additional experiments
were performed to ensure all cells were monitored for at least 3 h
following Smac release.
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Data are given as means±s.e.m. For statistical comparison
Student's t test or ANOVA and subsequent Tukey's test were used for
normal distributed data. P values smaller than 0.05were considered to
be statistically signiﬁcant.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamcr.2011.02.011.
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